British American Tobacco (BTI)
(Delayed Data from NYSE)
$35.29 USD
+0.18 (0.51%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $35.29 0.00 (0.00%) 6:14 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$35.29 USD
+0.18 (0.51%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $35.29 0.00 (0.00%) 6:14 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Zacks News
BTI or MO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BTI vs. MO: Which Stock Is the Better Value Option?
Is British American Tobacco (BTI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is British American Tobacco (BTI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BTI vs. MO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
BTI vs. MO: Which Stock Is the Better Value Option?
Should Value Investors Pick British American Tobacco (BTI)?
by Zacks Equity Research
Let's see if British American Tobacco (BTI) stock is a good choice for value-oriented investors right now from multiple angles.
Zacks.com featured highlights include: Bristol-Myers Squibb, Urban Outfitters, Hewlett Packard, Cardinal Health and British American Tobacco
by Zacks Equity Research
Zacks.com featured highlights include: Bristol-Myers Squibb, Urban Outfitters, Hewlett Packard, Cardinal Health and British American Tobacco
5 Excellent GARP Stocks With Discounted PEG
by Urmimala Biswas
PEG-based investing becomes more rewarding when other relevant parameters are considered.
Has British American Tobacco p.l.c. (BTI) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (BTI) Outperforming Other Consumer Staples Stocks This Year?
Should Value Investors Buy British American Tobacco (BTI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Philip Morris Trims View on Berlin Plant Closure Charges
by Zacks Equity Research
Charges of almost $355 million related to the closure of Berlin plant compel Philip Morris (PM) to trim 2019 earnings view. It now expects earnings of $4.53.
Will Pricing be an Upside for Altria (MO) in Q3 Earnings?
by Zacks Equity Research
Gains from pricing and savings efforts are likely to be reflected on Altria's (MO) Q3 results. However, receding cigarette sales volumes are a concern.
Will Cigarette Woes Hurt Philip Morris (PM) in Q3 Earnings?
by Zacks Equity Research
Philip Morris' (PM) Q3 performance to gain from pricing and IQOS expansion. However, low cigarette sales volumes are a worry.
Can Altria Battle Dwindling Cigarette Sales & Vaping Worries?
by Zacks Equity Research
Altria (MO) is reeling under regulatory pressures in the tobacco industry. However, higher pricing is likely to provide support.
Philip Morris (PM) Hikes Dividend to Boost Shareholders Value
by Zacks Equity Research
Philip Morris (PM) is consistently boosting shareholders' value via dividend payouts. The company announces dividend hike of 2.6%.
Trump May Ban Flavored E-Cigarettes: Who Wins, Who Loses
by Zacks Equity Research
Vaping is a growing trend among youngsters, but Trump's recent threat to ban flavored e-cigarettes raises questions. Will traditional cigarette get back its lost glory?
Altria (MO) in Talks to Unite With Philip Morris, Stock Down
by Zacks Equity Research
Altria (MO) is in discussions with Philip Morris to consider the prospects of a merger. The companies have not revealed further information regarding the development.
Here's Why Philip Morris (PM) Stock is Down 4.7% in 3 Months
by Zacks Equity Research
Philip Morris (PM) witnesses receding cigarette sales volumes. Nevertheless, advancement in low-risk tobacco alternatives is encouraging.
What to Expect from Altria Earnings as MO Stock Continues to Struggle
by Mitchell Moore
Altria Group (MO) stock is up just 1.5% so far in 2019 to lag behind the tobacco market's nearly 16% climb. Let's see if we should expect this underperformance to continue following the release of Altria's earnings report before the market opens on Tuesday, July 30, or might MO shares get a boost.
Smokeless Unit & Pricing to Boost Altria's (MO) Q2 Earnings
by Zacks Equity Research
Altria's (MO) Q2 performance is likely to gain from RRPs, high pricing and saving initiatives.
Can Low Cigarette Sales Hurt Philip Morris' (PM) Q2 Earnings?
by Zacks Equity Research
Philip Morris' (PM) Q2 performance to gain from pricing and advancements in RRPs. However, low cigarette sales volumes are a worry.
Philip Morris' Cigarette Sales Low, RRPs Stay in Demand (Revised)
by Zacks Equity Research
Philip Morris (PM), which struggles against persistent decline in cigarette sales, is resorting to expansion in RRPs.
Phillip Morris' Cigarette Sales Low, RRPs Stay in Demand
by Zacks Equity Research
Philip Morris (PM), which struggles against persistent decline in cigarette sales, is resorting to expansion in RRPs.
Can Smokeless Unit Help Altria Pare Low Cigarette Sales?
by Zacks Equity Research
Altria (MO) is undertaking efforts to expand in the RRPs space amid receding cigarette shipping volumes.
Big Tobacco Takes a Big Hit (MO) (PM) (BTI) (Revised)
by Zachary Stutler
Since Friday, Altria Group Inc. (MO), Philip Morris International Inc. (PM), and British American Tobacco PLC (BTI) have all fallen 5.1%, 5.9%, and 5.7% respectively as of market close on Wednesday, May 29. And opened Thursday with very little change.
Big Tobacco Takes a Big Hit (MO) (PM) (BTI)
by Zachary Stutler
Since Friday, Altria Group Inc. (MO), Philip Morris International Inc. (PM), and British American Tobacco PLC (BTI) have all fallen 5.1%, 5.9%, and 5.7% respectively as of market close on Wednesday, May 29. And opened Thursday with very little change.